- Super User
- Trials
- Read Time: 1 min
- Hits: 0
Recruitment of patients to the Phase III study 14-431 to evaluate the efficacy and safety of ABT-494 in patients with Crohn's disease has been properly completed.
Recruitment of patients to the Phase III study 14-431 to evaluate the efficacy and safety of ABT-494 in patients with Crohn's disease has been properly completed.
The selection for clinical trials RPC 01-3202 / RPC 01-3203 / RPC 01-3204 of phase III has been successfully completed. The purpose of the study: to evaluate the efficacy and safety of a new oral IP for patients with moderate or severe Crohn's disease.
Permission from the Ministry of Health of the Russian Federation has been obtained to conduct a clinical trial of GALACTIC-1 phase IIb for patients with Idiopathic Pulmonary Fibrosis.
A cooperation agreement has been concluded with SRG as a referral center to increase the enrollment of patients with Crohn's disease in phase II and III clinical trials.